Web Search: Goods Information jobs Download

        新闻分类
        Your present location:新闻首页 >> News >> Company news >> SyncoZymes successfully make Ibrutinib API on commercial production

        Font Size:big  middle  small

        SyncoZymes successfully make Ibrutinib API on commercial production

        Number of visits: Date:2016年6月10日 16:19

        After one year R&D, SyncoZymes become the first company in China that can make Ibrutinib API on commercial production. 

        Take part in the investigation Recommended by my friend

        TypeInfo: Company news

        Keywords for the information:API